Menu

Brain & Breathing

Funding

Canadian Institutes for Health Research (CIHR)

Project Grant. 2018-2023. Neural and Molecular Basis of Opioid-Induced Respiratory Depression. Principal Investigator: Gaspard Montandon.

St. Michael’s Hospital Foundation. Research Innovation Council

2018-2021. Identification of safe opioid pain therapies using drug screening in zebrafish. Principal Investigator: Gaspard Montandon.

Ontario Thoracic Society Grant-in-Aid

2017-2018. Mechanisms of opioid-induced respiratory depression. Principal Investigator: Gaspard Montandon.

Pettit Block Term Grant.

2017-2018. Division of Respirology. Department of Medicine. University of Toronto. Regulators of G-protein signaling regulate opioid-induced respiratory depression. Principal Investigator: Gaspard Montandon.

Innovative Research Program of the National Sanitarium Association

Support for this research team came from a partnership between the Innovative Research Program of the National Sanitarium Association in the Brain and Breathing (Richard L. Horner, PhD, Department of Medicine, PI and Director), the Department of Medicine (Dr. Gillian Hawker, Chair), and the Division of Respirology (Dr. T. D. Bradley, Director), and the Keenan Research Centre for Biomedical Science at St. Michael’s Hospital.

Parker B. Francis Fellowship Award. Parker B. Francis Foundation

2013-2016. Cellular mechanisms mediating opioid-induced respiratory depression. Principal Investigator: Gaspard Montandon.

J. P. Bickell Foundation Biomedical Grant

2019-2020. Drug discovery in larval zebrafish to identify safe pain opioid pain therapies. Principal Investigator. Gaspard Montandon

Team Breathe Award - Lung Health Foundation

2020-2021. Identification of new molecular pathways regulating opioid-induced respiratory depression. Principal Investigator. Gaspard Montandon

CIHR Early Career Investigator Award in Circulatory and Respiratory Health.

2020-2023. Mechanisms of opioid-induced respiratory depression. Principal Investigator. Gaspard Montandon